Selüler leiomyon ve leiomyosarkomlarda östrojen ve progesteron reseptör ekspresyonu
Amaç: Selüler leiomyom ve leimyo sarkomların Ostrojen ve progesteron reseptör ekspresyonlarını değerlendirmek. Materyal ve Method: 1997-2003 yıUarı arasında Zeynep Kamil Hastanesi Patoloji Bölümünde tanı almış 17 selüler leimyom ve 7 leiomyosarkom olgusu çalışma kapsamına alındı. Tümörleri temsil eden birer parafin blokda immunhisto kimyasal yöntemle östrojen ve progesteron reseptör boyanması incelendi. Bulgular: Leiomy'Osarkomların hiçbirinde progesteron resptörü için "overexpression"'(OE) izlenmedi. Onyedi adet selüler leibmyomun 13 ünde OE saptandı (LMS PR-OE x SM PR-OE, p
Estrogen and progesteron receptor expression in cellular leiomyomas and leiomyosarcomas
Objective:To evaluate estrogen(ER) and progesteron(PR) receptor expression in cellular leiomyomas and leiomyosarcomas Materials and Methods: The study includes 17 cases of cellular leiomyoma(CM) and 7 cases of leiomyosarcoma(LMS) which were diagnosed in Pathology Department of Zeynep Kamil Hoşpital between 1997 and 2003 years. One paraffin-embedded tümör tissue per each case were analyzed immunohistochemically for ER and PR ,receptors. Results: None of LMSs showed 'overexpression' for PR. Out-of 17 CMs 13 showed PR overexpression.(LMS PR overexpressionxCMPR overexpression,p
___
- 1. Zaloudek CJ, Hendrickson MR. Mesenchymal
tumors of the uterus. In: Kurman RJ, ed. Blaustein's
Pathology of Female Genital Tract. 5th ed. New
York: Springer-Verlag 2 002: 561-616
- 2. Buttrom VC, Reiter RC. Uterine leiomyomata:
etiology symptomatology and management. Fertil
Steril 1981, 36:433-5
- 3. Kamaguchi K, Fujii S, Konishi I, Nanbu Y,
Nonogaki H, Mori T. Mitotik activity in uterine
leimyoma during the menstrual cycle. Am J Obstet
Gynecoll989; 160: 637-41
- 4. Kawaguchi K, Fujii S, Konishi I, et al
- Immunohistochemical analysis of oestrogen
receptors, progesterone receptors and Ki-67 in
leiomyoma and myometrium during the menstruial
cycle and pregnancy. Virchoows Arch PatholAnat
1991, 419: 309-15
- 5. Brandon DD, Bethea CL, Strawn EY, et al
- Progesterone receptor messenger ribonucleic acid
and protein are overexpresses in human uterine
leiomyomas. Am ] Obstet Gynecol 1993; 169: 78-
85
- 6. Mittal K, Popiolek D, Demopoulos Rl. Uterine
myxoid leiomyosarcoma within a leiomyoma. Human
Pathol 2000; 31: 398-400
- 7. Scurry}, FRCPA, Hack M. Leiomyosarcoma
arising in a lipoleiomyosarcoma. Gynecol Oncol
1990; 39: 381-3
- 8. Montague A, Swariz DP, Woodruff JD. Sarcoma
arising in leiomyoma of uterus. Am J Obstet Gynecol
1965; 92: 421-7
- 9. Hendrickson MR, Kempson RL. Pure
mesenchymal neoplasms of the uterine corpus. In;
FoxH, Wells M. Eds. Obstetrical and Gynecological
Pathology. Vol 1. 5th edn. Edinburg, London ;
Churchill Livingstone; 2003 : 497-548
- 10. Carcangiu ML, Chambers JT, VaynickIM, Pino
M, Schwartz PE. Immunhis to chemical evaluation
of estrogen and progesterone receptor content in
183 patients with endometrial carcinoma. Part I:
clinical and histologic correlations. Am J Clin Pathol
1990; 94: 247-54
- 11. Kounelis S, Kapranos N, Kouri E. Et al
- Immuno his to chemical profile of endometrial
adenocarcinoma: astudy of 61 cases and review
of the literature. Mod Pathol 2000; 13: 379-88
- 12. Pertschuk LP, Masood S, Simone J. et al
Estrogen receptor immuno cytochemistry in
endometrial carcinoma: a prognostic marker for
survival. Gynecol Oncol 1996; 63: 28-33
- 13. Fukuda K, MoriM, Uchiyama M, IwaiK, Iwasaka
T, Sugimori H. Prognostic significance of
progesterone receptor immuno his to chemistry in
endometrial carcinoma. Gynecol Oncol 1998; 69:
220-5
- 14. Sivridis E, GiatromanolakiA, Koukourakis M,
Anastasiadis P. Endometrial carcinoma: association
with low angiogenesis andbcl-2 expression. Vfrhows
Arch 2001; 438: 470-7
- 15. IwaiK, Fukuda K, Hachisuga T. Etal. Prognostic
signicance of progesterone receptor
immunohistochemistry for lymph node metastases
in endometrial carcinoma. Gynecol Oncol 1999;
72: 351-9
- 16. ZhaiYL, KobayashiY, Mori A et al. Expression
of steroid receptors, Ki-67 and p 53 in uterine
leiomyosarcomas. IntJ Gynecol Pathol 1999; 18:
20-8
- 17. Mittal K, Demopoulos RI. MIB-1 (Ki-67), p 53,
estrogen receptor and progesterone receptor
expression in uterine smooth muscle tumors. Hum
Pathol 2001; 32: 984-7